CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo

BACKGROUND: Glioblastoma multiforme (GBM) remains to be one of the top lethal cancer types for adult to date. Current GBM therapies suffer greatly from the highly heterogeneous and adaptable nature of GBM cells, indicating an urgent need of alternative therapeutic options. In this study, we focused...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Manag Res
Autori principali: Meng, Wei, Wang, Jiajia, Wang, Baocheng, Liu, Fang, Li, Meng, Zhao, Yang, Zhang, Chenran, Li, Qifeng, Chen, Juxiang, Zhang, Liye, Tang, Yujie, Ma, Jie
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2018
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6245350/
https://ncbi.nlm.nih.gov/pubmed/30532595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S183696
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi